Related Experiment Video
Updated: Jun 1, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Characterization and outcomes of young infants with acute liver failure
Shikha S Sundaram1, Estella M Alonso, Michael R Narkewicz
1Department of Pediatrics, Section of Gastroenterology, Hepatology and Nutrition, The Children's Hospital, University of Colorado School of Medicine, Aurora, CO, USA. sundaram.shikha@tchden.org
Insights
Acute liver failure (ALF) in infants under 90 days shows better spontaneous survival than expected. Liver transplantation offers a viable option for infants with ALF, especially those with indeterminate or viral causes.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Neonatal Medicine
Background:
- Acute liver failure (ALF) in infants presents significant diagnostic and management challenges.
- Understanding the specific characteristics and outcomes of ALF in neonates and young infants is crucial for improving care.
Purpose of the Study:
- To characterize the clinical presentation, etiologies, and outcomes of infants aged 90 days or younger with acute liver failure.
- To analyze survival rates and the role of liver transplantation in this vulnerable population.
Main Methods:
- Analysis of prospective data from the international, multicenter Pediatric Acute Liver Failure (PALF) Study Group.
- Inclusion of infants aged ≤ 90 days enrolled in the registry before May 18, 2009.
Main Results:
- 148 infants with ALF were identified, with a median age of 18 days.
- Common etiologies included indeterminate causes (38%), neonatal hemochromatosis (13.6%), and herpes simplex virus (12.8%).
- Spontaneous survival was observed in 60% of infants, 16% received liver transplants, and 24% died without transplantation. Infants with indeterminate ALF had higher rates of liver transplantation compared to viral-induced ALF. Viral ALF was associated with a significantly higher cumulative incidence of death without transplantation.
Conclusions:
- Acute liver failure in young infants has distinct diagnostic considerations.
- Spontaneous survival rates for ALF in this age group are more favorable than previously reported.
- Liver transplantation serves as an important therapeutic option for infants with ALF, improving overall management and outcomes.
Objective:
To characterize infants aged ≤ 90 days enrolled in an international, multicenter, prospective registry of children aged < 18 years with acute liver failure (ALF).
Study Design:
The Pediatric Acute Liver Failure (PALF) Study Group collects prospective data on children from birth to 18 years. We analyzed data from infants aged ≤ 90 days enrolled in the PALF Study before May 18, 2009.
Results:
A total of 148 infants were identified in the PALF registry (median age, 18 days). Common etiologies of ALF were indeterminate (38%), neonatal hemochromatosis (13.6%), and herpes simplex virus (12.8%). Spontaneous survival occurred in 60% of the infants, 16% underwent liver transplantation, and 24% died without undergoing liver trsansplantation. Infants with indeterminate ALF were more likely to undergo liver transplantation than those with viral-induced ALF (P = .0002). The cumulative incidence of death without liver transplantation was higher in infants with viral ALF (64%) compared with those with neonatal hemochromatosis (16%) or indeterminate ALF (14%) (P = .0007).
Conclusion:
ALF in young infants presents unique diagnostic considerations. Spontaneous survival is better than previously thought. Liver transplantation provides an additional option for care.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pancreatitis I: Introduction
